DaVita
DVA
#2205
Rank
NZ$14.46 B
Marketcap
NZ$202.27
Share price
-0.32%
Change (1 day)
-25.02%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.16

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$17.23. In 2024 the company made an earnings per share (EPS) of NZ$19.12 an increase over its 2023 EPS that were of NZ$13.19.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.16-10.26%
2024NZ$19.1244.94%
2023NZ$13.1927.26%
2022NZ$10.37-35.56%
2021NZ$16.0944.1%
2020NZ$11.1719.7%
2019NZ$9.33540.48%
2018NZ$1.46-76.07%
2017NZ$6.09-19.31%
2016NZ$7.54242.52%
2015NZ$2.20-62.87%
2014NZ$5.9313.43%
2013NZ$5.238.45%
2012NZ$4.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
NZ$25.49 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.29-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
NZ$37.01 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.77 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA